PDK1 and hepatocellular carcinoma: Indeed, circARNT2 was highly expressed in cisplatin-resistant HCC tissues and functions as a tumor promotor by inhibiting miR-155-5p, leading to PDK1 overactivation and eventually resistance to cisplatin in HCC cells (71).